Atlas Trials

An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)

Clinical trial NCT00636961 · COMPLETED

Trial details

NCT number
NCT00636961
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2008-02-01
Primary completion
2008-08-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.